DOCSLIB.ORG

Review of the Science Base to Support the Development of Health Warnings for Tobacco Packages

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Review of the Science Base to Support the Development of Health Warnings for Tobacco Packages Sambrook Research International A review of the science base to support the development of health warnings for tobacco packages This report has been prepared for European Commission, Directorate General for Health and Consumers. The views expressed in this document are the sole responsibility of its authors and do not necessarily reflect the views of the European Commission. Sambrook Research International 30 Station Road Newport Ref : R 306 Shropshire 18th May 2009 TF10 7EN Tel 01952 551188 England Fax 01952 551163 E-mail : [email protected] Contents EXECUTIVE SUMMARY............................................................................. 1 Main findings and overall conclusions 1 Recommendations 4 BACKGROUND, OBJECTIVES, METHOD AND SAMPLE .................. 5 Background, objectives and overall research requirements 5 SCIENTIFIC KNOWLEDGE ON HEALTH LABELLING ..................... 7 How consumers look at packaging / labels 7 Effectiveness of warning labels generally 8 SCIENTIFIC KNOWLEDGE ON TOBACCO WARNING LABELS..... 9 Background information on tobacco warning labelling 9 Review of scientific knowledge on general tobacco warning labelling 10 Evaluation of the effectiveness of TEXT ONLY tobacco health warnings 14 Evaluation of the effectiveness of specific pictorial tobacco health warnings 20 PRINCIPLES OF EFFECTIVE TOBACCO WARNING LABELS ...... 40 Effectiveness of graphic warnings versus text only messages 40 Analysis of warning effectiveness 42 Key design parameters to create effective warning labels 46 SCIENTIFIC EVIDENCE OF HEALTH EFFECTS OF TOBACCO ... 49 Overview of the main illnesses related to smoking and second-hand smoke 49 Review of the scientific evidence of the health effects of tobacco 51 Health and other benefits from smoking cessation 80 PROPOSALS FOR NEW TOBACCO HEALTH WARNINGS.............. 81 Proposed new warning messages 81 OVERALL CONCLUSIONS AND RECOMMENDATIONS............... 108 Main findings and overall conclusions 108 Recommendations 110 APPENDICES ............................................................................................. 111 Appendix 1 – References regarding effectiveness of health warnings 112 Appendix 2 – Evidence on effectiveness of tobacco health warning labels in general 117 Appendix 3 – Evidence of effectiveness of pictorial warnings versus text only 127 Appendix 4 - Overview of tobacco warning messages used with pictorial warnings 131 Appendix 5 -Information on health labelling in non-tobacco sectors 135 Appendix 6 – The 42 pictorials used in the EU 141 Appendix 7 – Plain packaging and its likely impact 146 Appendix 8 – References regarding the health effects of smoking 149 Appendix 9 – List of people contacted for feedback 153 EXECUTIVE SUMMARY Main findings and overall conclusions • The purpose of this report is to provide the European Commission with a review of the scientific knowledge on health and tobacco labelling, an evaluation of the impact of the existing textual and pictorial warnings and a proposal for warning messages based on a state-of-the-art knowledge on tobacco-related harm. Scientific knowledge on health labelling generally • Consumers usually examine packaging in a systematic way, looking at the elements in order of visual dominance. Warning labels are more effective if they systematically address key behaviour processes – attention, reading, comprehension, recall, judgement, behaviour compliance. Scientific knowledge on the effect / impact of tobacco warning labels on consumers • There is clear evidence that tobacco package health warnings increase consumers’ knowledge about the health consequences of tobacco use and contribute to changing consumer’s attitudes towards tobacco use as well as changing consumers’ behaviour. They are also a critical element of an effective tobacco control policy. ¾ Warnings have a high impact in educating consumers of the health risks of tobacco use ¾ Warnings have a medium impact in changing smokers attitudes (in particular thinking about quitting and smoking in the presence of non-smokers) ¾ Warnings have a medium impact in changing smokers’ behaviour (including smoking less, smoking less around others, using quit lines, attempting to quit and quitting) Principles of effective tobacco warning labels • Combined pictorial + text warnings are significantly more effective than text only warnings, especially educating the public of the health risks and changing consumer behaviour. They are also more effective than text only in minimising ‘wear out’ over time. • Fear inducing warnings (using strong ‘shocking’ images related to health risks) and strong emotion inducing warnings (especially involving children and unborn babies) are the most effective way to educate consumers on the health risks of tobacco use and to achieve changes in attitudes and behaviour. These warnings’ effectiveness is enhanced if they are used in conjunction with advice on where to obtain help, e.g. a quit line. • Many warning messages have universal appeal. However, developing messages that target specific consumer groups is also of value. Certain messages clearly have higher resonance with one target group and less resonance with others. • The report provides detailed recommendations regarding the key design parameters and their optimum specification. The key parameters of importance are as follows: ¾ Size - optimally 100% and at least 50% (excluding borders) of the total facial area. ¾ Colour pictures used in all warnings together with short easily understood text messages that are clearly linked to the graphical image. ¾ Location – pictorial + text warnings should preferably be used on both sides, and as a minimum requirement on the front of packs. ¾ The warning should be hung from the top of the pack to maximise visibility. For packs that have a front opening mechanism, front warning should be hung from the ‘cut line’ (to avoid the warning being severed when the package is opened). ¾ Toll free quit line number on every pack – ideally this should be separate from the warning to avoid reducing the size (and impact) of the pictorial within the warning. 1 ¾ Plain packaging – using an unattractive standardised colour with the removal of logos / brand images and associated colours, with brand names in a standardised colour (black) and font size. Inserts that contain information on the immediate health benefits of quitting as well as advice on how to quit and details of the quit line number could also be considered. • Warnings should be optimally split into two sets, each set rotated ideally every 12 months (maximum every 18 months) to minimise wear out effects. • The optimum renewal period for the warning messages is broadly seen as every 2-5 years. If a rotation period of 12 months is adopted, then the warnings / images should be reviewed after 4 years (allowing each message to be used at least twice). Scientific evidence of the health effects of tobacco use • The key diseases associated with smoking for which the research shows there is strong evidence of a causal link are given below. DISEASES CAUSED BY ACTIVE SMOKING Cancer diseases Lung cancer (bronchus, trachea) Head / neck cancer (mouth, larynx, pharynx, oesophagus, nasal/sinus) Kidney / ureter cancer Pancreatic cancer Stomach cancer Bladder cancer Cervical cancer Leukaemia (especially acute myeloid leukaemia) Non- cancerous respiratory diseases Chronic obstructive pulmonary disease COPD (emphysema / chronic bronchitis) Other respiratory effects (asthma, coughing, phlegm, wheezing and dyspnoea) Pneumonia Cardiovascular diseases Heart attack / coronary heart disease / aortic aneurysm Angina Stroke Atherosclerotic / peripheral vascular disease Reproductive and pregnancy related diseases Male / female fertility Reduced foetal growth / low birth weight baby Miscarriage / spontaneous abortion Perinatal death Increased risk for sudden infant death syndrome Premature birth Premature rupture of the membrane Increased risk of placenta previa Increased risk of placental abruption Impotence / erectile dysfunction Other diseases Blindness / age related macular degeneration / cataracts; Ageing of the skin; Osteoporosis / hip fracture; Gastric ulcer; Dental disease; Other diseases that are associated with smoking where evidence is suggestive but not sufficient to infer a causal relationship include; anal cancer, vagina/ vulva cancer, ovarian cancer, penis cancer, prostate cancer, colorectal (bowel) cancer, liver cancer, breast cancer, chronic rhinitis, multiple sclerosis, goitre, diabetes and crohn’s disease asthma, breast cancer, rheumatoid arthritis. 2 DISEASES CAUSED BY SECOND-HAND SMOKE Diseases caused in adults Coronary heart disease; Lung cancer; Reproductive effects in women / low birth weight; Respiratory symptoms (nasal irritation) Diseases caused in children Middle ear disease; Sudden infant death syndrome (SIDS); Respiratory diseases; Other diseases that are associated with passive smoking where evidence is suggestive but not sufficient to infer a causal relationship include: Adults - nasal sinus cancer, stroke, COPD / asthma, AMD, atherosclerosis/ peripheral vascular disease and pre-term delivery. Children - brain tumours, lymphoma, asthma, leukaemia, meningitis, cognitive development and behaviour problems. Proposed new warning messages • 24 new warning messages have been developed, based on analysis of the scientific evidence, discussions during in-depth interviews and stakeholder feedback. Some have universal appeal others have additional resonance with specific age groups / gender.
Load more

Recommended publications
  • Project SUN: a Study of the Illicit Cigarette Market In
    Project SUN A study of the illicit cigarette market in the European Union, Norway and Switzerland 2017 Results Executive Summary kpmg.com/uk Important notice • This presentation of Project SUN key findings (the ‘Report’) has been prepared by KPMG LLP the UK member firm (“KPMG”) for the Royal United Services Institute for Defence and Security Studies (RUSI), described in this Important Notice and in this Report as ‘the Beneficiary’, on the basis set out in a private contract dated 27 April 2018 agreed separately by KPMG LLP with the Beneficiary (the ‘Contract’). • Included in the report are a number of insight boxes which are written by RUSI, as well as insights included in the text. The fieldwork and analysis undertaken and views expressed in these boxes are RUSI’s views alone and not part of KPMG’s analysis. These appear in the Foreword on page 5, the Executive Summary on page 6, on pages 11, 12, 13 and 16. • Nothing in this Report constitutes legal advice. Information sources, the scope of our work, and scope and source limitations, are set out in the Appendices to this Report. The scope of our review of the contraband and counterfeit segments of the tobacco market within the 28 EU Member States, Switzerland and Norway was fixed by agreement with the Beneficiary and is set out in the Appendices. • We have satisfied ourselves, so far as possible, that the information presented in this Report is consistent with our information sources but we have not sought to establish the reliability of the information sources by reference to other evidence.
    [Show full text]
  • Tobacco Community Fact Sheet
    Tobacco Community Fact Sheet Sterling, Massachusetts Updated 08/01/19 The Massachusetts Tobacco Cessation and Prevention Program The mission of the Massachusetts Tobacco Cessation and Prevention Program (MTCP) is to reduce the health and economic burden of tobacco use by preventing young people from starting to smoke, helping current smokers to quit, and protecting children and adults from secondhand smoke. The following provides data and information on the impact tobacco use has on your city or town, and the strategies being used in your community to combat these issues. % of Adult Smokers Cigarette Smoking 40 An estimated 631 smokers live in Sterling (10.7% of adults, age 30 18+). 20 The adult smoking rate is 22% lower in Sterling than statewide 13.7 (10.7% in Sterling compared to 13.7% statewide). 10.7 10 The rate of smoking during pregnancy in Sterling is 32% lower than statewide (4.6% in Sterling compared to 6.8% statewide). 0 Sterling MA Health Effects of Smoking Evidence has linked smoking to diseases of nearly all organs of the body. The Surgeon General’s report concludes that smoking causes: lung cancer, chronic obstructive pulmonary disease or lung disease, coronary heart disease, stroke, diabetes mellitus, rheumatoid arthritis and immune system weakness, increased risk for tuberculosis disease and death, ectopic (tubal) pregnancy and impaired fertility, erectile dysfunction, and age-related macular degeneration. Smoking can also trigger or make an asthma attack worse (2014 U.S. Surgeon General's Report). In Sterling, lung cancer incidence is 21% lower among males compared to the state of Massachusetts.
    [Show full text]
  • Creating a Future Free from Smoking, Vaping and Nicotine Extraordinary Achievements in a Year Like No Other
    CREATING A FUTURE FREE FROM SMOKING, VAPING AND NICOTINE EXTRAORDINARY ACHIEVEMENTS IN A YEAR LIKE NO OTHER 2020 ANNUAL REPORT TABLE OF CONTENTS 03 LETTER FROM THE CEO & PRESIDENT 05 YOUTH & YOUNG ADULT PUBLIC EDUCATION 13 RESEARCH & POLICY 21 COMMUNITY & YOUTH ENGAGEMENT 28 INNOVATIONS TO QUIT SMOKING, VAPING, AND NICOTINE 34 FINANCIAL STATEMENTS & BOARD OF DIRECTORS LETTER FROM CEO & PRESIDENT ROBIN KOVAL 2020 was a year like no other. In the face of a global powerful, comprehensive umbrella for all our youth- pandemic and unimaginable challenges, Truth facing national programs which have expanded Initiative remained laser-focused on its ultimate beyond prevention to include, cessation, education goal: saving lives. We intensified our efforts to and activism initiatives. In 2020, we launched six combat tobacco use as both a public health and truth campaign efforts with record engagement, social justice issue. We rapidly responded to including our first campaigns to fully integrate This national crises by providing our young audience is Quitting, our first-of-its-kind, free and anonymous with information to stay safe, healthy and to help text message quit vaping program tailored to young their communities, while working tirelessly to people. With more than 300,000 young people create a future that has never been more urgent: enrolled and strong results from our randomized one where tobacco and nicotine addiction are clinical trial — the first-ever for a quit vaping things of the past. As youth e-cigarette use persists intervention — This is Quitting is making a big impact. at epidemic levels and threatens to addict a new We brought the power of truth and This is Quitting generation to nicotine, we continue to lead the fight to classrooms and communities with Vaping: Know against tobacco use in all forms and launched an the truth, our first national youth vaping prevention update to our organization’s mission: achieve a curriculum that nearly 55,000 students have already culture where young people reject smoking, vaping, completed in just its first five months.
    [Show full text]
  • Tabak Und Zigaretten Der Vegan News-‐Einkaufsguide
    Tabak und Zigaretten Der Vegan News-Einkaufsguide VEGAN* Imperial Tobacco Quelle: www.imperial-tobacco.at/component/itrfile/?view=download&id=209 Davidoff JPS Drum R1 Ernte 23 Rizla Gauloises Route 66 Gauloises Brunes Stuyvesant Gitanes Van Nelle Golden Virginia West Von-Eicken Quelle: http://www.von-eicken.com/de/umweltschutz/ Allure Dockers Burton Manitou Organic Denim Pepe Dimitrinos St. Pauli Pöschl Tabak Quelle: E-Mail Anfrage Black Hawk Manila Bounty Pontiac Brookfield Pueblo Holland Art Red Bull JBR Turner *Vegan in Zusammenhang mit Zigaretten/Tabak meint an dieser Stelle, dass in den Produkten keine tierischen Inhaltsstoffe vorhanden sind sowie seitens des Unternehmens keine TierversuChe durChgeführt werden. Vegan News Stand: 31. Dezember 2015 NICHT FÜR VEGANER GEEIGNET Lorillard Tobacco Kent Old Gold Maverick Satin Max True Newport R.J. Reynolds Tobacco Company Barclay Monarch Belair More Capri Natural American Spirit Carlton Now Doral Salem Eclipse Tareyton GPC Vantage Kool Viceroy Misty Philip Morris Accord Diana Number 7 Alpine Dji Sam Soe Optima Apollo-Soyuz Eve Papastratos Assos English Ovals Parisienne Jaune Basic f6 Parliament Belmont Fajrant Peter Jackson Best Fortune Petra Bond Street Hope Philip Morris Boston Juwel Players Bristol Karo Polyot Bucks L&M Red & White Cambridge Lark Sampoerna A Canadian Classics Longbeach Saratoga Chesterfield Marlboro SG Classic Merit Sparta Collector’s Choice Moven Gold Start Commander Multi DeLuxe U Mild Daves Multifilter Vatra Delicados Muratti Virginia Slims Vegan News Stand: 31. Dezember 2015 British American Tobacco Dunhill Prince Fair Play Samson HB Schwarzer Krauser Javaanse Jongens Vogue Lord Vype (E-Zigarette) Lucky Strike Westpoint Pall Mall Japan Tobacco International Benson & Hedges Nil Camel Old Holborn Club Overstolz Coronas Peter I Ducat Reyno Export 'A' Ronson Glamour Russian Style M Salem Magna Silk Cut Mayfair Sobranie Memphis Sovereign Mi Ne St George Mild Seven Tawa Mercedes de Luxe Troika Monte Carlo Winston More Winchester Vegan News Stand: 31.
    [Show full text]
  • Annex 2: Description of the Tobacco Market, Manufacturing of Cigarettes
    EUROPEAN COMMISSION Brussels, 19.12.2012 SWD(2012) 452 final Part 3 COMMISSION STAFF WORKING DOCUMENT IMPACT ASSESSMENT Accompanying the document Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on the approximation of the laws, regulations and administrative provisions of the Member States concerning the manufacture, presentation and sale of tobacco and related products (Text with EEA relevance) {COM(2012) 788 final} {SWD(2012) 453 final} EN EN A.2 DESCRIPTION OF THE TOBACCO MARKET, MANUFACTURING OF CIGARETTES AND THE MARKET OF RELATED NON-TOBACCO PRODUCTS A.2.1. The tobacco market.................................................................................................. 1 A.2.1.1. Tobacco products.............................................................................................. 1 A.2.1.2. Tobacco manufacturing .................................................................................... 6 A.2.1.3. Tobacco growing .............................................................................................. 8 A.2.1.4. Tobacco distribution levels............................................................................... 9 A.2.1.5. Upstream/downstream activities..................................................................... 10 A.2.1.6. Trade............................................................................................................... 10 A.2.2. Tobacco and Society............................................................................................... 11 A.2.2.1.
    [Show full text]
  • Roc Background Document: Tobacco Smoking
    FINAL Report on Carcinogens Background Document for Environmental Tobacco Smoke December 2 - 3, 1998 Meeting of the NTP Board of Scientific Counselors Report on Carcinogens Subcommittee Prepared for the: U.S. Department of Health and Human Services Public Health Services National Toxicology Program Research Triangle Park, North Carolina 27709 Prepared by: Technology Planning and Management Corporation Canterbury Hall, Suite 310 4815 Emperor Boulevard Durham, NC 27703 Contract Number NOI-ES-85421 RoC Background Document for Environmental Tobacco Smoke Table of Contents Summary Statement..................................................................................................................v 1 Physical and Chemical Properties ......................................................................................1 1.1 Chemical Identification...........................................................................................1 2 Human Exposure.................................................................................................................9 2.1 Biomarkers of Exposure..........................................................................................9 2.1.1 Nicotine and Cotinine...............................................................................9 2.1.2 Carbon Monoxide and Carboxyhemoglobin ...........................................10 2.1.3 Thioethers ..............................................................................................10 2.1.4 Thiocyanate............................................................................................10
    [Show full text]
  • Pyramid Cigarettes
    ** Pyramid Cigarettes ** Pyramid Red Box 10 Carton Pyramid Blue Box 10 Carton Pyramid Menthol Gold Box 10 Carton Pyramid Menthol Silver Box 10 Carton Pyramid Orange Box 10 Carton Pyramid Red Box 100 10 Carton Pyramid Blue Box 100 10 Carton Pyramid Menthol Gold Box 100 10 Carton Pyramid Menthol Silver Box 100 10 Carton Pyramid Orange Box 100 10 Carton Pyramid Non Filter Box 10 Carton ** E Cigarettes ** Logic Disposable E Cigarette Menthol Gold 24 Box Logic Disposable E Cigarette Menthol High 24 Box Logic Disposable E Cigarette Menthol Platinum 24 Box Logic Disposable E Cigarette Menthol Sterling 24 Box Logic Disposable E Cigarette Menthol Zero 24 Box Logic Disposable E Cigarette Gold 24 Box Logic Disposable E Cigarette High 24 Box Logic Disposable E Cigarette Sterling 24 Box Logic Disposable E Cigarette Platinum 24 Box Logic Disposable E Cigarette Zero 24 Box ** Premium Cigars ** Acid Krush Classic Blue 5-10pk Tin Acid Krush Classic Mad Morado 5-10pk Tin Acid Krush Classic Gold 5-10pk Tin Acid Krush Classic Red 5-10pk Tin Acid Kuba Kuba 24 Box Acid Blondie 40 Box Acid C-Note 20 Box Acid Kuba Maduro 24 Box Acid 1400cc 18 Box Acid Blondie Belicoso 24 Box Acid Kuba Deluxe 10 Box Acid Cold Infusion 24 Box Ambrosia Clove Tiki 10 Box Acid Larry 10-3pk Pack Acid Deep Dish 24 Box Acid Wafe 28 Box Acid Atom Maduro 24 Box Acid Nasty 24 Box Acid Roam 10 Box Antano Dark Corojo Azarosa 20 Box Antano Dark Corojo El Martillo 20 Box Antano Dark Corojo Pesadilla 20 Box Antano Dark Corojo Poderoso 20 Box Natural Dirt 24 Box Acid Liquid 24 Box Acid Blondie
    [Show full text]
  • Family Smoking Prevention and Tobacco Control Act’’
    H. R. 1256 One Hundred Eleventh Congress of the United States of America AT THE FIRST SESSION Begun and held at the City of Washington on Tuesday, the sixth day of January, two thousand and nine An Act To protect the public health by providing the Food and Drug Administration with certain authority to regulate tobacco products, to amend title 5, United States Code, to make certain modifications in the Thrift Savings Plan, the Civil Service Retirement System, and the Federal Employees’ Retirement System, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, DIVISION A—FAMILY SMOKING PRE- VENTION AND TOBACCO CONTROL ACT SECTION 1. SHORT TITLE; TABLE OF CONTENTS. (a) SHORT TITLE.—This division may be cited as the ‘‘Family Smoking Prevention and Tobacco Control Act’’. (b) TABLE OF CONTENTS.—The table of contents of this division is as follows: Sec. 1. Short title; table of contents. Sec. 2. Findings. Sec. 3. Purpose. Sec. 4. Scope and effect. Sec. 5. Severability. Sec. 6. Modification of deadlines for Secretarial action. TITLE I—AUTHORITY OF THE FOOD AND DRUG ADMINISTRATION Sec. 101. Amendment of Federal Food, Drug, and Cosmetic Act. Sec. 102. Final rule. Sec. 103. Conforming and other amendments to general provisions. Sec. 104. Study on raising the minimum age to purchase tobacco products. Sec. 105. Enforcement action plan for advertising and promotion restrictions. Sec. 106. Studies of progress and effectiveness. TITLE II—TOBACCO PRODUCT WARNINGS; CONSTITUENT AND SMOKE CONSTITUENT DISCLOSURE Sec. 201. Cigarette label and advertising warnings.
    [Show full text]
  • 2015 Annual Report
    2015 Annual Report 2015 Philip Morris Annual Report_March 1- Layout_49 Dear Shareholder, PMI delivered a very strong performance in 2015, despite an increasingly complex business environment, as well as the sharp André Calantzopoulos Louis C. Camilleri Chief Executive Officer Chairman of the Board appreciation of the U.S. dollar, which acted as a significant drag the European Union (EU), Eastern Europe, Middle East & Africa (EEMA) and Latin America & Canada (LA&C) Regions. This was our on our reported results. best cigarette volume performance, excluding acquisitions, since 2012, driven mainly by a moderation in the cigarette industry volume decline, notably in the EU Region. This performance underscores the resilience of our business, our Our market share performance in 2015 was strong. Total PMI broad and balanced geographic footprint, the strength of our world- share, excluding China and the U.S., increased by 0.2 percentage class brand portfolio and, above all, the motivation and focus of our points to 28.7%, with growth in the EU, EEMA and LA&C Regions of organization. 0.1, 0.3 and 0.5 percentage points, respectively, and stable share in Against a backdrop of improving industry volume trends in many Asia. Importantly, we registered a growing or essentially flat share in key geographies, our cigarette brand portfolio performed superbly, 20 of our top-30 operating companies income (OCI)(2) markets. driven by the Marlboro 2.0 Architecture, our enhanced commercial Marlboro, the number one cigarette brand worldwide, enjoyed a approach and the investments that we made in 2014 to address key very robust performance, driven by the continued roll-out of the 2.0 market challenges.
    [Show full text]
  • Tool 2. Stakeholder-Specific Arguments for Tobacco Control
    TOOL 2. STAKEHOLDER-SPECIFIC ARGUMENTS FOR TOBACCO CONTROL This tool provides arguments to convince different sectors and stakeholders to support and actively engage in tobacco control and actively participate in the NCM. The tool will also help health ministry officials answer questions from representatives of other sectors, and articulate a clear vision for why a whole-of-government approach is critical for tobacco control and related sustainable development objectives. Efforts to generate whole-of-government responses to tobacco control typically fail where tobacco is presented as a health challenge only. NCM engagement should be presented as more than just a benefit to, and responsibility of, the health sector. Clear, convincing and sector-specific arguments can take several forms, discussed below. Those involved in tobacco control planning should consider which line of argument or combination of arguments is most likely to persuade in a given context. The first argument is to emphasize whole-of-government efforts and policy coherence as necessary to fulfill WHO FCTC obligations. Entire governments sign the WHO FCTC, and thus it is legally incumbent upon all relevant government sectors to implement the treaty’s provisions. This means that different sectors are legally obliged to reconcile any contradictions between their mandates and the WHO FCTC. That the WHO FCTC is a legally binding international treaty, with reporting requirements, should be considered in priority setting discussions across ministries. Ministries could also be
    [Show full text]
  • Tobacco Flavoring Fact Sheet 2020
    Tobacco Flavoring THE HISTORY AND WHERE WE ARE NOW In 2009, the Family Smoking Prevention and Tobacco Control Act gave the U.S Food and Drug Administration the authority to regulate tobacco products, including cigarettes, cigarette tobacco, roll-your-own tobacco, and smokeless tobacco.1 The bill also banned the sale of flavored cigarettes, except for menthol. In 2016, the FDA extended its regulatory authority to all “tobacco products” including electronic cigarettes and other electronic nicotine delivery systems (ENDS), cigars, hookah, pipe tobacco, nicotine gels, dissolvables not already subject to regulation, and other products that might meet the definition of “tobacco product” in the future.1 FDA has only just begun to take steps to regulate these newer products -- over 15,000 different e-cigarette flavors currently exist in the marketplace leading to an epidemic of youth use, and relatively few studies have been conducted to investigate the safety and inhalation toxicity for flavored products.2 In January 2020, the FDA issued guidance that removed some flavored cartridge-based electronic nicotine delivery systems (ENDS) from the market. However, the policy failed to include menthol- or tobacco-flavored cartridge-based e-cigarettes, any flavored disposable e-cigarettes, and e-liquids used in refillable, open tank systems. Menthol is one of the most common flavor additives used in cigarettes and other tobacco products, accounting for 36% of the cigarette market in the U.S in 2018 and an increase in sales from 10.7% to 61.% among prefilled e-cigarette cartridges in 2020.3,4 A 2013 FDA analysis concluded that menthol cigarettes may increase youth initiation, and there has been great scientific debate on the role of menthol in nicotine dependence and cessation..5 The use of menthol cigarettes is particularly prevalent among youth adults and African Americans.
    [Show full text]
  • Current Population Survey, July 2018: Tobacco Use Supplement File That Becomes Available After the File Is Released
    CURRENT POPULATION SURVEY, July 2018 Tobacco Use Supplement FILE Version 2, Revised September 2020 TECHNICAL DOCUMENTATION CPS—18 This file documentation consists of the following materials: Attachment 1 Abstract Attachment 2 Overview - Current Population Survey Attachment 3a Overview – July 2018 Tobacco Use Supplement Attachment 3b Overview-Tobacco Use Supplement NCI Data Harmonization Project Attachment 4 Glossary Attachment 5 How to Use the Record Layout Attachment 6 Basic CPS Record Layout Attachment 7 Current Population Survey, July 2018 Tobacco Use Supplement Record Layout Attachment 8 Current Population Survey, July 2018 Tobacco Use Supplement Questionnaire Attachment 9 Industry Classification Codes Attachment 10 Occupation Classification Codes Attachment 11 Specific Metropolitan Identifiers Attachment 12 Topcoding of Usual Hourly Earnings Attachment 13 Tallies of Unweighted Counts Attachment 14 Countries and Areas of the World Attachment 15 Allocation Flags Attachment 16 Source and Accuracy of the July 2018 Tobacco Use Supplement Data Attachment 17 User Notes NOTE Questions about accompanying documentation should be directed to Center for New Media and Promotions Division, Promotions Branch, Bureau of the Census, Washington, D.C. 20233. Phone: (301) 763-4400. Questions about the CD-ROM should be directed to The Customer Service Center, Bureau of the Census, Washington, D.C. 20233. Phone: (301) 763-INFO (4636). Questions about the design, data collection, and CPS-specific subject matter should be directed to Tim Marshall, Demographic Surveys Division, Bureau of the Census, Washington, D.C. 20233. Phone: (301) 763-3806. Questions about the TUS subject matter should be directed to the National Cancer Institute’s Division of Cancer Control and Population Sciences, Behavior Research Program at [email protected] ABSTRACT The National Cancer Institute (NCI) of the National Institutes of Health (NIH) and the U.S.
    [Show full text]